Related Experiment Video
Updated: Sep 4, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
Hydroxyurea and cellular senescence in non-transformed cells
Milica Vukotić1, Juan F Santibanez2
1Group for Molecular Oncology, Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, Dr. Subotica 4, POB 102, Belgrade, 11129, Serbia.
Abstract:
Hydroxyurea (HU) is a growth-inhibiting agent used to treat conditions characterized by excessive cellular proliferation. As an antimetabolite, HU inhibits ribonucleotide reductase, reducing the deoxyribonucleotide pool and thereby slowing DNA synthesis. Pharmacological inhibition of cell division is closely associated with the development of a cellular senescence phenotype, which may contribute to therapeutic resistance and tumor-associated inflammation. This phenotype has extensive effects, potentially inducing bystander effects and fostering tumor immunosuppression, thereby increasing the risk of cancer recurrence or relapse. Furthermore, HU has been shown to induce cellular senescence in non-malignant cells in laboratory settings. This review examines the principal molecular mechanisms underlying HU's cytotoxic and genotoxic effects, as well as the salient features of cellular senescence induction. A comprehensive understanding of the pathways through which HU prompts cellular senescence in normal cells may enhance current chemotherapy strategies and mitigate adverse effects in patients with cancer and other pathologies.
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
Mitochondria
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Replication in Eukaryotes
Overview of DNA Repair
Chemically...
